Business Update Positive

2026-11-09 15:01

Management Guidance & Outlook - Raised FY27 revenue growth guidance to low double digits (up from high single to low double digits earlier). - Maintained EBIT margin target band of 14.75% to 15.75%. - Targeting 80% conversion of net income to operating cash flow in FY27, normalizing further in FY28. Business Performance & Deal Wins - Q2 delivered strongest sequential CC growth in three years; Direct business grew 3.5% QoQ and 11.3% YoY in CC. - Net new TCV stood at $466 million (6th consecutive quarter above $400 million), with trailing-twelve-months TCV at $1.8 billion. - Closed 5 large deals in Q2; AI-led deals represented 66% of quarterly TCV wins. - Total pipeline reached a record high, expanding 4.4% QoQ and 23% YoY, with 71% being AI-led. Growth Drivers & Trends - Broad-based vertical performance: BFS Direct grew 4.5% QoQ / 15% YoY CC, while TMT Direct grew 10.9% QoQ. - Strong traction in shorter-cycle deals (<$20M TCV), up 35% YoY in the pipeline, driving faster revenue conversion. - Mphasis Tria platform is scaling, unlocking new business and operations budgets outside traditional IT. Cash Flow & Working Capital - Operating cash flow generation was $34 million after normalizing $39.5 million of collections in transit on Sep 30. - Normalized DSO rose to 105 days due to a quarterly aberration, expected to return to double digits in Q3.

Business Update Positive

2026-11-09 14:57

Management Guidance & Outlook - Raised FY27 revenue growth guidance to low double digits (up from high single digits to low double digits previously). - Reaffirmed FY27 EBIT margin guidance band at 14.75% to 15.75%. - Maintained full-year target of 80% conversion of net income to operating cash flow, with further normalization expected in FY28. Deal Wins & Pipeline Trends - Q2 net new TCV stood at $466 million (66% AI-led), keeping trailing twelve months (TTM) TCV at $1.8 billion with five large deal wins. - Total pipeline reached a record high, growing 23% YoY and 4.4% QoQ; deals under $20 million rose 35% YoY reflecting strong short-cycle demand. Growth Drivers & AI Strategy - Mphasis Tria platform is unlocking larger multi-year, outcome-based transformation deals beyond traditional IT into business and operations budgets. - Growth was led by BFS (up 4.5% QoQ, 15.0% YoY in Direct constant currency) and TMT (up 10.9% QoQ in Direct constant currency). Cash Flow & Working Capital - Operating cash flow generation was $34 million, impacted by $39.5 million of remittances initiated on September 30 and received in October. - Normalized DSO rose to 105 days due to the collections spillover, with management expecting a return to double digits in Q3.

Routine Neutral

2026-11-08 23:21

- MphasiS Limited has approved the allotment of 1,52,891 equity shares on 8 November 2026 pursuant to the exercise of employee stock options and restricted stock units. - Breakdown includes 15,500 shares under ESOP 2016 and 1,37,391 shares under RSU Plan 2021. - The employee trusts will utilize a portion of shares to cover exercise prices and taxes.

Routine Neutral

2026-11-08 23:14

- Mphasis Ltd announced the allotment of 1,52,891 equity shares under its ESOP 2016 and RSU Plan 2021. - Breakdown includes 15,500 shares under ESOP 2016 and 1,37,391 shares under RSU Plan 2021. - Appropriate shares will be deducted by the respective Trusts to cover exercise prices and applicable taxes under approved cashless schemes.

Business Update Neutral

2026-11-06 18:03

- Audio recording of Investor/Analyst call held on November 6, 2026, is available on the company's website. - The call pertained to financial results for the quarter and half-year ended September 30, 2026.

Business Update Neutral

2026-11-06 18:02

- Audio recording of the Investor/Analyst call held on November 6, 2026, has been made available on the company's website. - The call was conducted in connection with the financial results for the quarter and half year ended September 30, 2026.

Financials Neutral

2026-11-05 23:50

Q2 FY27 Consolidated Revenue ₹4,581Cr vs ₹3,902Cr (▲17% YoY) EBITDA ₹829Cr vs ₹722Cr (▲15% YoY) PAT ₹561Cr vs ₹469Cr (▲20% YoY) EBITDA Margin 18.1% vs 18.5% (▼40bps)

Financials Neutral

2026-11-05 23:48

Q2 FY27 Consolidated Revenue ₹4,581Cr vs ₹3,902Cr (▲17% YoY) EBITDA ₹829Cr vs ₹722Cr (▲15% YoY) PAT ₹561Cr vs ₹469Cr (▲20% YoY) EBITDA Margin 18.1% vs 18.5% (▼39bps)

Financials Neutral

2026-11-05 23:48

Q2 FY27 Consolidated Revenue ₹4,581Cr vs ₹3,902Cr (▲17% YoY) EBITDA ₹829Cr vs ₹722Cr (▲15% YoY) PAT ₹561Cr vs ₹469Cr (▲20% YoY) EBITDA Margin 18.1% vs 18.5% (▼39bps)

Business Update Positive

2026-10-22 11:57

- Mphasis received official validation for its near-term and net-zero greenhouse gas (GHG) emissions reduction targets from SBTi Services. - The company aims to achieve net-zero GHG emissions across its value chain by FY 2050 using FY 2024-25 as the baseline. - Near-term targets include a 66.01% reduction in absolute Scope 1 and Scope 2 emissions by FY 2036. - The company also aims to achieve carbon neutrality across facilities and operations by FY 2030.

Business Update Positive

2026-10-22 11:56

Mphasis' near-term and net-zero greenhouse gas emissions reduction targets have received official validation from SBTi Services. - The company aims to achieve net-zero emissions across its value chain by FY 2050, using FY 2025 as the baseline year. - Near-term targets include a 66.01% reduction in absolute Scope 1 and Scope 2 GHG emissions by FY 2036. - Mphasis also reported meeting 57.82% of its energy needs from renewable sources and achieving an improved CRISIL Core ESG score of 73 in FY 2026.

Routine Neutral

2026-10-14 18:15

- Mphasis received an income tax rectification order under Section 154 for Assessment Year 2023-24. - The tax demand has been revised upward from ₹2,286.86 crore to ₹2,417.80 crore due to interest levied under Section 220. - The company plans to file a rectification petition and evaluate legal remedies. - The company does not expect any material impact on its financial statements.

Routine Negative

2026-10-14 18:14

CRITICAL RED FLAG DETECTED

- Mphasis Ltd received a rectification order under Section 154 of the Income-tax Act, 1961 for Assessment Year 2023-24 on October 13, 2026. - The tax demand has been revised upwards from ₹2,286.86 crore to ₹2,417.80 crore due to interest levied under Section 220. - The company plans to file an appropriate rectification petition for computational errors and does not expect any material financial impact.

Ownership Neutral

2026-10-13 10:50

- HDFC Mutual Fund increased its shareholding in Mphasis Ltd by 2.06% through open market purchases. - Post-acquisition, HDFC Mutual Fund's aggregate holding stands at 7.06% (1,34,73,462 equity shares) as of October 8, 2026. - Previous holding was reported at 5.02% as of January 16, 2026.

Governance Neutral

2026-10-10 20:48

- MphasiS Limited has approved the grant of 107,578 options on 10 October 2026. - Granted 64,434 Stock Options under ESOP 2016 at an exercise price of ₹2,300 with a 5-year vesting period. - Granted 43,144 RSUs under RSU Plan 2021 at an exercise price of ₹10 with a 4-year vesting period.

Routine Neutral

2026-10-10 20:43

- Mphasis Ltd announced the grant of 64,434 Stock Options under ESOP 2016 at an exercise price of ₹2,300 per option with a 5-year vesting period. - The company also granted 43,144 Restricted Stock Units (RSUs) under RSU Plan 2021 at an exercise price of ₹10 per RSU, vesting over 4 years.

Business Update Neutral

2026-10-09 15:34

Concall Schedule Concall Date: Friday, November 6, 2026 Concall Time: 08:30 AM IST

Business Update Neutral

2026-10-09 15:33

Concall Schedule Concall Date: Friday, November 06, 2026 Concall Time: 08:30 AM IST

Governance Neutral

2026-10-08 09:49

- Mphasis Limited has approved the grant of 3,25,460 Stock Options under ESOP 2016 at an exercise price of ₹2,300 per option with a 5-year vesting period. - The company also approved the grant of 1,63,040 RSUs under RSU Plan 2021 at an exercise price of ₹10 per RSU with a 4-year vesting period. - Grant Date for both options and RSUs is 1 October 2026.

Governance Neutral

2026-10-08 09:44

- Mphasis Ltd announced the grant of 3,25,460 Stock Options under ESOP 2016 at an exercise price of ₹2,300 per option with a 5-year vesting period. - The company also granted 1,63,040 RSUs under RSU Plan 2021 at an exercise price of ₹10 per RSU with a 4-year vesting period. - Grant Date for both options and RSUs is 1 October 2026.

Ownership Neutral

2026-10-08 08:41

- Kotak Mahindra Mutual Fund sold 1,23,216 equity shares (0.0645%) of Mphasis Limited. - The transaction took place on October 05, 2026, through an open market sale. - Post-transaction holding stands at 1,38,18,996 shares, representing 7.237% stake down from the previous 7.3015%.

Business Update Positive

2026-10-06 15:41

Order Win: Mphasis Limited won an order from Social Security Scotland Order Value: Approximately £35.4 million Completion Timeline: Not explicitly specified (ongoing maintenance and management partnership)

Business Update Positive

2026-10-06 15:40

Order Win: Mphasis Ltd won order from Social Security Scotland Order Value: £35.4 million Completion Timeline: Not specified

Business Update Positive

2026-09-22 11:24

- Mphasis and Copa Airlines hosted a Global Quantum Computing Challenge to accelerate innovation in airline operations, specifically passenger re-accommodation. - The challenge engaged teams from IITs and Canadian universities to leverage quantum computing for optimization. - Mphasis affirmed its commitment to advancing applied innovation in quantum technologies.

Business Update Positive

2026-09-22 11:22

- Mphasis, in partnership with Copa Airlines, hosted a Global Quantum Computing Challenge to accelerate innovation in airline operations. - The challenge involved top academic teams solving real-world airline optimization problems using quantum computing. - This initiative reinforces Mphasis' commitment to advancing quantum technologies for enterprise-scale applications.

Governance Neutral

2026-09-21 20:35

- Board Meeting scheduled for Thursday, November 05, 2026, to approve audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. - Trading window to close from September 23, 2026, to November 7, 2026. - Earnings Conference Call for Investors and Analysts on Friday, November 06, 2026, at 8:30 AM Indian Standard Time.

Routine Neutral

2026-09-21 19:06

- Trading window for Mphasis Limited's designated persons will close from September 23, 2026. - It will reopen 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026. - The Board Meeting date to approve these results will be communicated separately.

Routine Neutral

2026-09-21 19:00

- Trading window for Mphasis Limited will close for designated persons from September 23, 2026. - It will reopen 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026 (Q2 FY27). - The date of the Board Meeting to approve these financial results will be communicated separately.

Business Update Neutral

2026-09-16 13:36

- Investor Meet Schedule - Meet Date: September 21, 2026 - Conference: J.P. Morgan India Conference - Type of Meeting: One-One & Group - Location: Mumbai

Business Update Neutral

2026-09-16 13:35

- Concall Schedule - Concall Date: September 21, 2026 - Call Details: Mphasis Limited to participate in J.P. Morgan India Conference with One-One & Group meetings in Mumbai.

Ownership Neutral

2026-09-16 11:00

- Mphasis Limited approved the allotment of 64,800 Equity Shares on September 16, 2026. - These shares were allotted against the exercise of Employee Stock Options (ESOPs) under the ESOP 2016 plan.

Ownership Neutral

2026-09-16 10:54

- Mphasis allotted 64,800 Equity Shares on September 16, 2026. - Shares were allotted upon the exercise of Employee Stock Options under the ESOP 2016 plan.

Business Update Positive

2026-09-15 15:05

- Mphasis and Plaksha University hosted the second 'TrackShift Innovation Challenge' (Sept 12-13, 2026) to foster future-ready talent in AI, computer vision, and predictive modeling, attracting over 3600 applications. - The challenge focused on real-world motorsport engineering problems. Winning teams received cash prizes and mentorship-based internships.

Business Update Positive

2026-09-15 15:03

- Mphasis and Plaksha University hosted the second 'TrackShift Innovation Challenge' on Sept 12-13, 2026. - It engaged 180+ students in AI, computer vision, and predictive modeling for motorsport engineering problems. - Winning teams received cash prizes and internships.

Business Update Positive

2026-09-11 09:30

- Mphasis, in collaboration with SGBS Unnati Foundation and BMRCL, launched an environmental sustainability initiative for a "greener Bengaluru". - Efforts include maintaining metro corridors, water conservation, lake rejuvenation, and afforestation. - Mphasis aims to conserve 153 million litres of rainwater through 1,200 percolation wells and support planting 100,000 trees by 2026.

Business Update Positive

2026-09-11 09:30

- Mphasis has partnered with SGBS Unnati Foundation and BMRCL for a "Greener Bengaluru" environmental sustainability initiative. This CSR effort includes maintaining metro corridors, water conservation, afforestation, and establishing percolation wells to conserve 153 million liters of rainwater by 2026.

Governance Positive

2026-09-07 21:13

- On September 7, 2026, Mphasis Limited approved the cancellation of previously granted 4,15,060 ESOP 2016 Options and 92,400 RSU Plan 2021 RSUs, which were initially approved on August 20, 2026. - Concurrently, the company granted 1,01,030 Options under ESOP 2016 at an exercise price of ₹2,371, vesting over 5 years. - Additionally, 22,510 RSUs were granted under RSU Plan 2021 at an exercise price of ₹10, vesting over 4 years.

Ownership Neutral

2026-09-07 21:09

- Mphasis Limited allotted 7,800 Equity Shares on September 7, 2026, upon exercise of Employee Stock Options under ESOP 2016.

Governance Neutral

2026-09-07 21:04

- Mphasis announced the cancellation of 4,15,060 ESOP 2016 options and 92,400 RSU 2021 units, previously approved on August 20, 2026. - Concurrently, 1,01,030 options under ESOP 2016 at ₹2,371 exercise price (5-year vesting) and 22,510 RSUs under RSU Plan 2021 at ₹10 exercise price (4-year vesting) were granted, effective September 7, 2026.

Ownership Neutral

2026-09-07 20:43

- Mphasis Limited allotted 7,800 Equity Shares on September 7, 2026. - These shares were issued against the exercise of Employee Stock Options under the ESOP Plan 2016.

Business Update Neutral

2026-09-03 22:01

- Concall Schedule - Concall Date: September 9, 2026 - Details: Mphasis will participate in the BofA India IT virtual call series (Group Meeting, Virtual).

Business Update Neutral

2026-09-03 22:00

- Concall Schedule - Concall Date: September 9, 2026 - Event: BofA India IT virtual call series

Business Update Positive

2026-09-03 13:54

- Mphasis Limited received an overall ESG rating of '75' from NSE Sustainability Ratings and Analytics Limited. - The rating was independently assigned based on publicly available information.

Business Update Positive

2026-09-03 13:53

- Mphasis has been assigned an overall ESG rating of '75' by NSE Sustainability Ratings and Analytics Limited. It was independently assigned based on publicly available information.

Business Update Positive

2026-09-02 06:44

- Mphasis signed a strategic agreement with TechnoPro Holdings to accelerate AI-led enterprise transformation in Japan. - This partnership introduces Mphasis' AI-powered offerings (Modernize™, Optimize™) to the Japanese market. - Focus sectors include financial services, manufacturing, automotive, and technology.

Business Update Positive

2026-09-02 06:43

- Mphasis and TechnoPro Holdings signed a strategic agreement to accelerate AI-led enterprise transformation in Japan. - The partnership will introduce Mphasis' AI-powered offerings (Modernize™ and Optimize™) to the Japanese market. - The collaboration focuses on system modernization, business process advancement, and engineering advancement using AI agents, initially targeting financial services and manufacturing sectors.

Routine Neutral

2026-08-21 21:49

- Mphasis granted 415,060 Employee Stock Options (ESOP 2016) at ₹2,371/option, vesting over 5 years. - Also granted 92,400 Restricted Stock Units (RSU Plan 2021) at ₹10/RSU, vesting over 4 years, on 20 August 2026.

Ownership Neutral

2026-08-21 21:42

- Mphasis allotted 700 Equity Shares on August 21, 2026. - These shares were issued against the exercise of Restricted Stock Units (RSUs) under the RSU Plan 2021.

Governance Positive

2026-08-21 21:35

- Mphasis Limited granted 415,060 Employee Stock Options (ESOPs) under ESOP 2016 at an exercise price of ₹2,371 and 92,400 Restricted Stock Units (RSUs) under RSU Plan 2021 at an exercise price of ₹10 on August 20, 2026.

Ownership Neutral

2026-08-21 21:08

- Mphasis Limited's ESOP Compensation Committee approved the allotment of 700 Equity Shares on August 20, 2026. - These shares are against the exercise of Restricted Stock Units (RSUs) under the RSU Plan 2021.

Business Update Neutral

2026-08-14 21:57

- Mphasis received an ESG Score (Adjusted) of 72.6 (Grade B) for FY 2025-26 from SES ESG Research Private Limited. This is a decrease from FY 2024-25's score of 74.5 (Grade B). The rating was independently assigned.

Business Update Neutral

2026-08-14 21:55

- Mphasis Limited received an independently assigned ESG Score of 72.6 (Grade B) for FY 2025-26 from SES ESG Research Private Limited. - The score for FY 2024-25 was 74.5 (Grade B).

Business Update Neutral

2026-08-07 15:23

- Mphasis Limited to participate in multiple investor/analyst meetings: - Aug 12, 2026: Emkay Confluence 2026 Conference (One-One & Group, Mumbai) - Aug 13, 2026: Equirus Annual India Conference (One-One & Group, Mumbai) - Aug 18, 2026: Motilal Oswal Annual Global Investor Conference, 2026 (One-One & Group, Mumbai)

Business Update Neutral

2026-08-07 15:22

- Mphasis to participate in Analyst / Institutional Investor meets. - Scheduled conferences: Emkay Confluence 2026 (Aug 12, 2026), Equirus Annual India Conference (Aug 13, 2026), Motilal Oswal Annual Global Investor Conference 2026 (Aug 18, 2026). All meetings are One-One & Group in Mumbai. - No Unpublished Price Sensitive Information will be shared.

Business Update Positive

2026-08-06 15:55

- Mphasis's overall ESG rating upgraded to 'Crisil ESG 67' from 'Crisil ESG 64'. - Core ESG rating upgraded to 'Crisil Core ESG 73' from 'Crisil Core ESG 69' by Crisil ESG Ratings & Analytics Limited.

Business Update Positive

2026-08-06 15:55

- Mphasis's overall ESG rating upgraded to 'Crisil ESG 67' from 'Crisil ESG 64'. - Core ESG rating upgraded to 'Crisil Core ESG 73' from 'Crisil Core ESG 69'. - The rating was independently assigned by CRISIL ESG Ratings & Analytics Limited.

Business Update Positive

2026-07-31 18:18

- Mphasis Limited received a Silver Medal in the EcoVadis Sustainability Assessment for FY2026. - The company achieved an overall score of 75 out of 100, placing it in the 87th percentile.

Business Update Positive

2026-07-31 18:16

- Mphasis awarded Silver Medal in EcoVadis Sustainability Assessment for FY2026. - The company achieved an overall score of 75 out of 100, demonstrating strong performance in sustainability.

Routine Neutral

2026-07-31 15:21

- Mphasis Limited allotted 3,606 Equity Shares on 31 July 2026. - This allotment includes 3,400 shares under ESOP 2016 and 206 shares under RSU Plan 2021, following approval by the ESOP Compensation Committee.

Ownership Neutral

2026-07-31 15:13

- Mphasis allotted 3,606 Equity Shares on July 31, 2026. - Shares were allotted against the exercise of Employee Stock Options (3,400 shares) and Restricted Stock Units (206 shares). - The Mphasis Employees Equity Reward Trust will deduct shares to cover exercise price and taxes, with proceeds used to repay company loans.

Business Update Positive

2026-07-28 13:35

- Q1 FY27 revenue grew 2.1% sequentially and 8.3% YoY in constant currency to $471 million. - Net new TCV for Q1 was $461 million, marking the fifth consecutive quarter above $400 million, including three large deals. - Pipeline has grown to an all-time high, 2.8 times its original size, with AI-led deals now forming 70%. - Q2 is positioned to deliver the best sequential constant currency growth in three years. - Maintains FY27 guidance for high single-digit to low double-digit constant currency growth and EBIT margin of 14.75%-15.75%. - Q1 EBIT margin was impacted by ramp-up costs for new deal wins and TAP acquisition, with normalization expected over the year. - Operating cash flow conversion is expected at 80% of net income through FY27. - The Mphasis Tria™ platform shows strong early traction, driving recurring, platform-attached revenue and elevating client conversations to business outcomes.

Business Update Positive

2026-07-28 13:32

- Mphasis Tria platform has shown stronger than anticipated traction, with multiple opportunities moving from conversation to closure within seven weeks of launch. - Q2 FY27 is expected to deliver the best sequential constant currency growth in three years, driven by record pipeline and strong short-cycle deal activity. - The company maintains its FY27 guidance for high single-digit to low double-digit constant currency growth and EBIT margin target of 14.75% to 15.75%. - Operating cash flow conversion is expected to remain at 80% of net income through FY27, with OCF to PAT conversion normalizing from FY28. - Net new TCV for Q1 FY27 was $461 million, marking the fifth consecutive quarter above $400 million, including one deal over $100 million. - The total pipeline grew 28% YoY, with AI-led deals now constituting 70% of the pipeline, up from 12%. - The AI strategy focuses on "Enterprise Agency" to deliver measurable economic outcomes, elevating client conversations to business leaders. - EBIT margin for Q1 FY27 was impacted by 60 bps due to ramp-up costs for new deal wins and the TAP acquisition, which are considered investments for future growth. - Insurance and TMT are expected to be key growth drivers through the remainder of FY27.

Ownership Neutral

2026-07-27 16:51

- Promoter BCP Topco IX Pte. Ltd. disclosed the refinancing of existing financing arrangements for Mphasis Limited on May 19, 2026. - The previous encumbrance was released, and a new one created on May 15, 2026, without affecting the promoter's 30.55% shareholding. - This new encumbrance secures a facility of up to USD 550 million.

Business Update Neutral

2026-07-24 14:44

- Audio recording of the Investors/Analysts call held on July 24, 2026, concerning Q1 FY27 financial results is available. - The recording can be accessed on the company's website.

Business Update Neutral

2026-07-24 14:42

- The audio recording of the Investor(s)/Analyst(s) call held on July 24, 2026, in connection with the financial results for the quarter ended June 30, 2026, is available on the company's website.

Governance Negative

2026-07-24 10:11

CRITICAL RED FLAG DETECTED

- Mphasis received notices from BSE and NSE for non-compliance with SEBI Regulation 17(1) for quarters ended December 31, 2025, and March 31, 2026, primarily related to Board composition. - Fines of ₹35,400 (inclusive of GST) per exchange were levied for the March 31, 2026, quarter. - The company has filed a waiver application, the outcome of which is awaited. - Failure to resolve could lead to freezing of promoter shares or suspension of trading.

Governance Negative

2026-07-24 10:11

CRITICAL RED FLAG DETECTED

- Mphasis received notices from BSE & NSE for alleged non-compliance with SEBI Regulation 17(1) (board composition, including failure to appoint a woman director) for Q4 FY26 and Q3 FY26. - A fine of ₹35,400 (inclusive of GST) was levied for the non-compliance in Q4 FY26. - The company has applied for a waiver of the fines, the outcome of which is awaited. - Stock exchanges warned of potential actions including freezing promoter shareholding and shifting trading to Z-category if non-compliance persists.

Financials Positive

2026-07-23 23:59

- Consolidated Revenue ₹4,384.05 Cr vs ₹3,732.49 Cr (▲17.5% YoY) - EBITDA ₹795.50 Cr vs ₹702.87 Cr (▲13.2% YoY) - PAT ₹489.51 Cr vs ₹441.70 Cr (▲10.8% YoY) - EBITDA Margin 18.15% vs 18.83% (▼68bps) - Board approved a final dividend of ₹62 per equity share for the year ended March 31, 2026.

Financials Positive

2026-07-23 23:56

- Consolidated Revenue ₹4,384.05Cr vs ₹3,732.49Cr (▲17.5% YoY) - EBITDA ₹795.50Cr vs ₹702.87Cr (▲13.2% YoY) - PAT ₹489.51Cr vs ₹441.70Cr (▲10.8% YoY) - EBITDA Margin 18.14% vs 18.83% (▼69bps)

Financials Positive

2026-07-23 23:53

- Consolidated Revenue ₹43,840.54Mn vs ₹37,324.89Mn (▲17.46% YoY) - EBITDA ₹7,955.00Mn vs ₹7,028.68Mn (▲13.18% YoY) - PAT ₹4,895.06Mn vs ₹4,417.03Mn (▲10.82% YoY) - EBITDA Margin 18.15% vs 18.83% (▼68bps) - A final dividend of ₹62 per equity share for the year ended March 31, 2026, has been approved by shareholders.

Financials Positive

2026-07-23 23:52

- Consolidated Revenue ₹43,841 Mn vs ₹37,325 Mn (▲17.5% YoY) - EBITDA ₹7,955 Mn vs ₹7,029 Mn (▲13.2% YoY) - PAT ₹4,895 Mn vs ₹4,417 Mn (▲10.8% YoY) - EBITDA Margin 18.15% vs 18.83% (▼68bps)

Financials Positive

2026-07-23 23:50

- Consolidated Revenue ₹4,384.05Cr vs ₹3,732.49Cr (▲17.46% YoY) - EBITDA ₹795.50Cr vs ₹702.87Cr (▲13.18% YoY) - PAT ₹489.51Cr vs ₹441.70Cr (▲10.82% YoY) - EBITDA Margin 18.15% vs 18.83% (▼68bps) - New Total Contract Value (TCV) wins of USD 461 Million, with 63% AI-led. - Management expects further acceleration in sequential growth in Q2 FY27.

Governance Positive

2026-07-23 22:53

- The 35th Annual General Meeting (AGM) of Mphasis Limited was held on July 23, 2026. All resolutions proposed in the Notice of AGM were duly passed by the members. Key resolutions included adoption of financial statements for FY26, declaration of a final dividend of ₹62 per equity share, and re-appointment of directors including the CEO & MD.

Governance Positive

2026-07-23 22:52

- The 35th Annual General Meeting (AGM) was held on July 23, 2026. All resolutions were passed with requisite majority. Resolutions included the adoption of financial statements, declaration of a final dividend of ₹62 per equity share, and re-appointment of directors, including the CEO and Managing Director.

Governance Positive

2026-07-23 15:18

- The 35th Annual General Meeting (AGM) of Mphasis Limited was held on July 23, 2026. - Members approved the adoption of financial statements for FY 2025-26. - A final dividend of ₹62/- per equity share for FY 2025-26 was declared. - Re-appointment of directors and CEO & MD Mr. Nitin Rakesh for 5 years was approved.

Governance Positive

2026-07-23 15:17

- The 35th Annual General Meeting (AGM) was held on July 23, 2026, through video conferencing. - Shareholders approved the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. - A final dividend of ₹62/- per equity share for FY ended March 31, 2026, was declared. - Re-appointments of various directors and Mr. Nitin Rakesh as MD & CEO for 5 years were approved. - Management highlighted strong performance in FY26 with AI-led growth and reaffirmed confidence in the Company's long-term strategy.

Business Update Positive

2026-07-23 10:58

- Chairperson's speech at the 35th Annual General Meeting held on July 23, 2026. - Noted complex macro environment and enterprises' hesitation in AI adoption due to rapid change and lack of a clear playbook. - Mphasis is helping clients navigate AI transformation, with New TCV wins growing 68% to USD 2.1 billion in FY26. - 60% of new TCV wins and 69% of the pipeline are AI-led. - Expressed confidence in translating strong pipeline and TCV growth into sustained revenue growth.

Governance Positive

2026-07-23 10:56

- Chairperson's speech at the 35th AGM on July 23, 2026. - Highlights strong FY26 TCV wins of USD 2.1B (60% AI-led) and 69% AI-led pipeline, despite a complex macro environment. - Expresses confidence in converting pipeline to revenue growth.

Governance Neutral

2026-07-20 23:41

- Mphasis Limited issued an Addendum to the Notice of its 35th Annual General Meeting (AGM) scheduled for July 23, 2026. - The addendum clarifies details regarding the re-appointment and remuneration structure of Mr. Nitin Rakesh (CEO & MD), specifying that remuneration shall not exceed 5% (or potentially 7% under specific conditions) of net profits.

Business Update Neutral

2026-07-07 15:23

- Concall Schedule - Concall Date: Friday, July 24, 2026 - Concall Time: 08:30 AM Indian Standard Time (IST)

Governance Positive

2026-07-02 15:33

- Submitted a revised Annual Report for the financial year 2025-26, which now includes the Chairman's Statement. - Notice is given for the 35th Annual General Meeting (AGM) to be held on Thursday, July 23, 2026, at 9:00 am (IST). - Agenda for the AGM includes adoption of financial statements for FY26, declaration of a final dividend of ₹62 per equity share, and re-appointment of directors and KMP.

Governance Positive

2026-07-02 14:59

- Submission of Revised Annual Report for FY 2025-26, updated with Chairman's Statement. - Notice of 35th Annual General Meeting to be held on Thursday, July 23, 2026. - Final dividend of ₹62/- per equity share for FY 2025-26 recommended. - Re-appointment of Ms. Maureen Anne Erasmus as Independent Director and Mr. Nitin Rakesh as CEO & MD.

Governance Neutral

2026-07-01 20:41

- Mphasis Limited's 35th Annual General Meeting (AGM) is scheduled for Thursday, 23 July 2026, at 9:00 a.m. (IST) via Video Conferencing. - The company has provided weblinks for the Notice of AGM and Annual Report for FY 2025-26 to shareholders. - The Record Date for the Final Dividend is Wednesday, 8 July 2026, and the dividend payment date is on or before Friday, 21 August 2026.

Governance Positive

2026-07-01 20:13

- Mphasis Limited's 35th Annual General Meeting (AGM) will be held on Thursday, July 23, 2026, at 9:00 am (IST) via Video Conferencing/OAVM for FY 2025-26. - Board recommends a final dividend of ₹62/- per equity share for FY 2025-26. - Key re-appointments include Mr. Kabir Mathur, Mr. Pankaj Sood (Directors), Ms. Maureen Anne Erasmus (Independent Director), and Mr. Nitin Rakesh (CEO & MD) for a 5-year term.

Governance Positive

2026-07-01 19:50

- Notice of the 35th Annual General Meeting (AGM) to be held on Thursday, July 23, 2026, at 9:00 am (IST) via Video Conferencing/OAVM. - The Board recommended a final dividend of ₹62/- per equity share of face value ₹10/- for the financial year ended March 31, 2026. - The Record date for the final dividend is Wednesday, July 8, 2026, with payment on or before Friday, August 21, 2026, if approved. - Key resolutions include re-appointment of directors, an Independent Director, and the CEO & Managing Director.

Business Update Positive

2026-06-29 13:00

- Mphasis announced joining the Microsoft Intelligent Security Association (MISA) on June 29, 2026. This collaboration integrates Mphasis' AI-driven cybersecurity solutions with Microsoft Security technology to enhance client defense against cyber threats.

Routine Neutral

2026-06-22 16:50

- Trading window for designated persons closed from June 23, 2026, until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. - The date of the Board Meeting to approve the results will be communicated separately.

Ownership Neutral

2026-06-14 12:34

- Mphasis Limited allotted a total of 11,867 Equity Shares following the exercise of Employee Stock Options (ESOPs) and Restricted Stock Units (RSUs). - This allotment includes 10,678 shares under ESOP 2016 and 1,189 shares under RSU Plan 2021. - The ESOP Compensation Committee approved the allotment on June 13, 2026.

Business Update Neutral

2026-06-09 16:57

- Investor Meet Schedule - Meeting Date: June 12, 2026 - Conference: Confluence, Investec Conference - Type: One-One & Group - Location: Chennai

Business Update Positive

2026-05-27 14:34

Mphasis launched Mphasis Tria™, a new Enterprise Agency Platform, to unify enterprise insight, foresight, and execution. The platform introduces two new market-facing product lines, Mphasis Modernize™ and Mphasis Optimize™, designed to accelerate the company's evolution into a platform-led AI enterprise. This strategic initiative aims to deliver outcome-led enterprise transformation and establish a scalable commercial model with measurable outcomes and recurring revenue potential.

Business Update Neutral

2026-05-22 19:16

Mphasis Limited announced its schedule for analyst/institutional investor meets in June 2026. The company will participate in the Axis Capital Rising Stars Conference on June 1, Morgan Stanley India Investment Forum on June 2, and Citi 2026 India Conference on June 4. All meetings will be held in Mumbai and no Unpublished Price Sensitive Information will be shared.

Governance Neutral

2026-05-22 17:57

Mphasis Limited announced the grant of 72,010 stock options under the ESOP 2016 plan, with an exercise price of ₹2,220 per option, vesting over 5 years. Additionally, 24,000 Restricted Stock Units (RSUs) were granted under the RSU Plan 2021 at an exercise price of ₹10 per RSU, vesting equally over 4 years, to identified employees on May 21, 2026.

Business Update Positive

2026-05-22 17:57

Mphasis Limited's ESOP Compensation Committee approved the grant of 72,010 Employee Stock Options (ESOPs) under the ESOP 2016 Plan at an exercise price of ₹2,220, vesting over 5 years. Additionally, 24,000 Restricted Stock Units (RSUs) under the RSU Plan 2021 were granted at an exercise price of ₹10, vesting over 4 years, to identified employees on May 22, 2026. This initiative aims to incentivize and retain talent.

Ownership Neutral

2026-05-22 17:48

Mphasis Limited announced the allotment of 2,507 Equity Shares on May 22, 2026. This comprises 1,988 shares against the exercise of Employee Stock Options under the ESOP 2016 Plan and 519 shares against the exercise of Restricted Stock Units under the RSU Plan 2021. The shares were allotted following a resolution passed by the ESOP Compensation Committee.

Business Update Positive

2026-05-21 21:38

Mphasis announced a partnership with the Indian School of Business (ISB) to establish an 'AI Hub'. The Mphasis F1 Foundation will invest approximately ₹20 crore over the next four years in Phase 1 to advance AI-led research and applied AI solutions, initially focusing on the healthcare and finance sectors.

Business Update Neutral

2026-05-11 08:22

Mphasis Limited announced it will host an Investor/Financial Analyst Day on Wednesday, May 27, 2026, at 9:00 a.m. IST in Mumbai. The physical meeting will be attended by institutional investors and financial analysts. The presentations for the event will be submitted to the Stock Exchanges and made available on the company's website.

Business Update Neutral

2026-05-07 18:21

Mphasis Limited announced its participation in the DAM Capital IT Investor conference on May 13, 2026, for one-on-one and group meetings in Mumbai. The company clarified that no Unpublished Price Sensitive Information will be shared during the conference.

Ownership Neutral

2026-05-07 17:49

Mphasis Limited, on May 7, 2026, allotted a total of 39,193 Equity Shares to employees upon exercise of Employee Stock Options (37,750 shares under ESOP 2016) and Restricted Stock Units (1,443 shares under RSU Plan 2021). Shares deducted by the Mphasis Employees Equity Reward Trust to cover exercise price and applicable taxes will be used to repay loans from the company.

Business Update Negative

2026-05-06 13:08

CRITICAL RED FLAG DETECTED

Mphasis Limited has received an order from the Joint Commissioner of Commercial Taxes (Appeals-5), Bengaluru, imposing a penalty of Rs. 1,941,007 (approx. 19.41 lakhs) under Section 73(9) of the Karnataka Goods and Services Tax Act, 2017. The penalty is for late reversal of input tax credit, non-submission of SEZ endorsement, and issues with the determination of place of supply for export transactions. The company stated that there is no impact on its financial, operational, or other activities.

Business Update Positive

2026-05-04 18:52

Management guided for FY27 high single-digit to low double-digit revenue growth, supported by AI-led transformation and strong deal conversion. They expect to maintain an EBITDA margin within the 14.75%-15.75% target band and an operating cash flow to net income conversion ratio of approximately 80%. Key growth drivers include the NeoIP platform, recent acquisition of Theory and Practice (Continuum AI) for decision intelligence, and continued strong performance in BFS and Insurance verticals. The company achieved its highest-ever annual net new TCV of over $2.1 Bn in FY26, with 69% of its pipeline now AI-led, reflecting a strategic shift towards business and operational transformation through AI. Hedge losses are anticipated to impact margins in H1 FY27, gradually tapering off.

MPHASIS

Mphasis Ltd

Price Chart

Filing History

Unlock Full History